BC
CASM

Broadfin Capital’s CAS Medical Systems, Inc. CASM Stock Holding History

Broadfin Capital’s Portfolio CASM Stock Details CASM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-562,030
Closed -$972K – 74
2016
Q3 		$972K Sell
562,030
-248,822
-31% -$432K 0.09% 68
2016
Q2 		$1.49M Sell
810,852
-1,683,682
-67% -$3.16M 0.15% 64
2016
Q1 		$3.54M Sell
2,494,534
-123,762
-5% -$201K 0.34% 56
2015
Q4 		$4.63M Hold
2,618,296
– – 0.29% 67
2015
Q3 		$3.27M Hold
2,618,296
– – 0.18% 75
2015
Q2 		$3.35M Hold
2,618,296
– – 0.18% 84
2015
Q1 		$3.5M Buy
2,618,296
+700,000
+36% +$1.01M 0.27% 70
2014
Q4 		$3.17M Hold
1,918,296
– – 0.28% 65
2014
Q3 		$3.72M Buy
1,918,296
+493,500
+35% +$851K 0.39% 54
2014
Q2 		$2.86M Hold
1,424,796
– – 0.28% 64
2014
Q1 		$3.09M Buy
1,424,796
+75,000
+6% +$159K 0.3% 70
2013
Q4 		$2.29M Buy
1,349,796
+48,900
+4% +$76.3K 0.3% 52
2013
Q3 		$1.74M Buy
1,300,896
+1,080,352
+490% +$1.59M 0.31% 51
2013
Q2 		$368K Buy
+220,544
New +$408K 0.07% 50

Other funds holding CASM

ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
TCM
TD Capital Management Memphis, Tennessee $1.11B AUM 10.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Broadfin Capital's CASM Position: Q4 2016 in Review

Broadfin Capital sold out of CAS Medical Systems, Inc. (CASM) in Q4 2016, closing a stake of 562,030 shares — an estimated $972K sold.

Broadfin Capital first reported a position in CASM in Q2 2013 and held it in 14 quarters. The position peaked at $4.63M in Q4 2015. 19 funds tracked by Wall St. Rank hold CASM as of Q4 2016.

  • Broadfin Capital reported no remaining CAS Medical Systems, Inc. position as of Q4 2016 after selling out during the quarter.
  • Broadfin Capital sold 562,030 CAS Medical Systems, Inc. shares in Q4 2016, an estimated $972K.
  • Broadfin Capital first reported a position in CAS Medical Systems, Inc. in Q2 2013 and held it in 14 quarters.
  • Broadfin Capital's CAS Medical Systems, Inc. position peaked at $4.63M in Q4 2015.
  • 19 funds tracked by Wall St. Rank held CAS Medical Systems, Inc. as of Q4 2016.

Based on Broadfin Capital's 13F filing for Q4 2016, filed 14 Feb 2017.